A major discovery in cancer research is occurring with the use of nanobodies to restore mutated p53. This essential malignant inhibitor protein is frequently inactivated in various forms of tumors, leading uncontrolled https://bookmarkcolumn.com/story21734871/mini-antibodies-reactivate-p53-the-new-approach-for-cancer-management